Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography
NCT ID: NCT06074731
Last Updated: 2023-10-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2017-06-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Spectral-domain Optical Coherence Tomography of the Eye
NCT02614625
Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures
NCT03461978
Retinal Investigation Using Optos OCT Device
NCT06846151
Wide Field OCTA in Ocular Diseases
NCT07298174
Novel Diagnostics With Optical Coherence Tomography: Imaging the Anterior Eye
NCT00343473
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SS-OCT system Plex Elite 9000
We will use a commercially available SS-OCT system (Plex Elite 9000; Carl Zeiss Meditec).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to follow instructions during imaging procedure
* Written Informed consent
Exclusion Criteria
* Inability to follow instructions during imaging procedure
* Patients who do not give informed consent
5 Years
110 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johannes Kepler University of Linz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matthias Bolz
Head of Ophthalmology and Optometry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthias Bolz, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Department for Ophthalmology, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department for Ophthalmology and Optometry, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria
Linz, Upper Austria, Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Matthias Bolz, Prof.Dr.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KUK-Ophthalmology-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.